NEW YORK--(BUSINESS WIRE)--Tyto
Care Inc. announced today that the U.S. Food and Drug Administration
(FDA) has granted 510(k) clearance for its digital stethoscope, a device
that will be part of its advanced set of examination tools now being
introduced to the world of telehealth. Tyto Care is launching a
comprehensive telehealth solution that includes state-of-the-art digital
tools for examining the ears, throat, skin, heart, lungs, and
temperature and a cloud-based platform with video conferencing. By
enabling a more comprehensive picture of the patient’s health and an
enhanced remote diagnosis, Tyto Care is providing the critical missing
link in the delivery of telehealth.
Until today, telehealth was limited because clinicians had to rely on
phone or video conferencing only to examine and diagnose a patient,
without the benefit of a physical exam. By providing vital physical exam
data, Tyto extends the reach of the clinician beyond the four walls of
the clinic. “For the first time we are making it possible to closely
replicate, from home, a face-to-face visit to the doctor’s office,” said
Dedi Gilad, CEO and Co-Founder of Tyto Care. “Tyto is providing the
missing link that will help telehealth realize its full potential.”
TytoCare’s modular exam tools and fully integrated telehealth platform
enable a remote examination of the heart, lungs, heart rate,
temperature, throat, skin and ears. Examinations can be done in real
time as part of a live video telehealth visit, or in advance of a
telehealth session (“exam and forward”). The company is introducing two
new products: TytoPro™ for clinicians to capture and share remote
examination data, conduct a specialist consultation, or get a second
opinion, and TytoHome™ for consumers to use at home to connect with a
clinician. TytoHome includes proprietary guidance technology that
enables anyone to easily and reliably capture exam data at home.
“By enabling a physical examination that virtually replicates an
in-person visit, TytoCare will greatly enhance the ability of
school-based clinics, nurses, home health providers, patients and family
caregivers to connect and share medical information,” commented Karen S.
Rheuban, MD, Pediatric Cardiologist, Past President of the American
Telemedicine Association, and Chair of Tyto Care’s Advisory Board. “The
use of digital technologies that support high quality remote
examinations, when integrated into care delivery models that enhance
access both within the context of the medical home and in other
settings, promises to transform how patients are treated today.
Consumers have demonstrated a strong desire for timely, convenient
access to care. TytoCare offers an innovative and important solution to
ensure that such care is of high quality, is convenient and meets the
standards of the in-person visit.”
Tyto Care, which has already received widespread interest within the
telehealth industry and medical community, is currently rolling out its
solution through strategic partnerships with large health systems,
physician groups and telehealth companies.
About Tyto Care
Tyto Care’s mission is to delight consumers and clinicians alike by
delivering easy, affordable and high quality telehealth visits, complete
with medical exams, all from the comfort of home.
The company is introducing two telehealth products, TytoHome for
consumers and TytoPro for professionals. TytoHome connects consumers to
clinicians for a comprehensive medical examination and remote telehealth
visit anywhere and anytime. TytoPro enables clinicians to capture and
share remote examination data, conduct a specialist consultation, or get
a second opinion.
Tyto Care was founded by Dedi Gilad, Ofer Tzadik and industry experts in
2012. The company has received over $18 million in funding from
investors including Cambia Health Solutions, Walgreens, Orbimed and
Fosun Pharma. See www.tytocare.com.
Click here to see a demo video of TytoCare - https://youtu.be/v8rwFMW5VhI